Royalty Pharma Total Non-Operating Income/Expense 2019-2024 | RPRX
Royalty Pharma total non-operating income/expense for the twelve months ending September 30, 2024 was $0.170B, a 805.52% decline year-over-year.
- Royalty Pharma annual total non-operating income/expense for 2023 was $0.208B, a 370.05% decline from 2022.
- Royalty Pharma annual total non-operating income/expense for 2022 was $-0.077B, a 59.37% decline from 2021.
- Royalty Pharma annual total non-operating income/expense for 2021 was $-0.19B, a 277.86% decline from 2020.